News
FDA approves new treatment for hospital-acquired, ventilator-associated bacterial pneumonia
June 4, 2019
The new indication is based on results of a multinational, double-blind study involving a different antibacterial drug.
News
CBO predicts more Medicare spending with drug rebate proposal
May 9, 2019
The Congressional Budget Office estimates that spending in the Medicare program would increase by $170 billion over the 2020-2029 period due to the proposed drug rebate changes.
News
Measles cases for 2019 now at postelimination high
April 25, 2019
“With a safe and effective vaccine that protects against measles, the suffering we are seeing is avoidable,” said HHS Secretary Alex Azar.
News
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing.
News
Report: Part B funds stable, hospital trust running out
April 24, 2019
Annual report shows Medicare’s Part B trust fund is secure, while Medicare’s Part A trust fund will deplete in 7 years.
News
MAT access helps address opioid use disorder
April 18, 2019
PHILADELPHIA – Incarceration is an accelerant in the crisis of opioid use disorder.
News
ONC’s Dr. Rucker: Era of provider-controlled data is over
April 3, 2019
WASHINGTON – Interoperability going forward means putting the power in the hands of the patients, according to the government’s top health data official.
News
FDA chief calls for stricter scrutiny of electronic health records
March 22, 2019
The government spent more than $36 billion over 10 years to switch to digital records. In that time, thousands of reports of deaths, injuries, and near misses linked to EHRs have piled up in databases – including at least one run by the FDA.
News
The power of policy at HM19
March 15, 2019
Featured speaker will be Dr. Reena Duseja, acting director of the Quality Measurement and Value-based Incentives Group at CMS.
News
Scott Gottlieb to step down as FDA commissioner
March 5, 2019
Scott Gottlieb, MD, will be stepping down from his post as commissioner of the Food and Drug Administration in about a month.